非结节性硬化症双肾巨大血管平滑肌脂肪瘤精准诊断及同期两侧手术治疗1例及文献复习

doi:10.6040/j.issn.1671-7554.0.2022.0352

摘要/Abstract

摘要： 目的探讨双肾巨大血管平滑肌脂肪瘤的精准诊断及一切口同期手术治疗的安全性及预后。方法回顾性分析1例双肾巨大血管平滑肌脂肪瘤患者的临床病例资料。患者,女性,18岁,BMI:20.96,因“触及腹部肿物2周”入院。术前双肾增强CT诊断为双肾巨大血管平滑肌脂肪瘤,CT三维重建进一步明确肿瘤位置、血供等信息。结果排除相关禁忌后,在气管插管全麻下同期采用腹部正中纵行切口行双肾血管平滑肌脂肪瘤切除术。术中见双肾周多发血管平滑肌脂肪瘤包绕肾脏,游离后切除双肾可见外生血管平滑肌瘤,手术顺利,术后常规病理结果示:(双侧肾)血管平滑肌脂肪瘤。患者术后住院10 d,无术后出血、肾衰、漏尿等并发症发生,随访至今患者未见转移、复发征象。结论双肾巨大血管平滑肌脂肪瘤除了临床症状体征诊断,必要时建议结合基因检测、影像学重建等精准诊断,制定手术计划,且一切口同期手术治疗两侧安全、可行。

关键词: 肾血管平滑肌脂肪瘤, CT三维重建, 基因检测, 手术治疗

Abstract: Objective To explore the accurate diagnosis and the safety and prognosis of simultaneous resection of giant angiomyolipoma of both kidneys. Methods Clinical data of a patient with giant angiomyolipoma of both kidneys were retrospectively analyzed. The 18-year-old female patient with body mass index(BMI)of 20.96 kg/m² was admitted due to “palpable abdominal mass for 2 weeks”. Preoperative enhanced CT showed giant angiomyolipoma of both kidneys. Three-dimensional reconstruction of CT further clarified the tumor location, blood supply and other information. Results After exclusion of relevant contrain dications, bilateral resection was performed simultaneously with midline abdominal incision under general anesthesia. There were multiple angiomyolipomas around the kidneys. After dissociation, they were resected successfully. Routine pathological results indicated(bilateral)angiomyolipomas. During the 10-day postoperative hospitalization, no bleeding, renal failure or urinary leakage occurred. During the 12-month follow-up, no metastasis or recurrence was observed. Conclusion In addition to clinical symptoms and signs, gene detection, imaging reconstruction and other accurate diagnosis are necessary to formulate the surgical plan. Simultaneous resection of bilateral giant angiomyolipomas through one incision is safe and feasible.

Key words: Renal angiomyolipoma, CT three-dimensional reconstruction, Gene detection, Surgical treatment

中图分类号:

R737.11

马臣帮,高沛,常耀,毛昌琳,陈峰,朱可嘉,管勇,李善军,丁森泰. 非结节性硬化症双肾巨大血管平滑肌脂肪瘤精准诊断及同期两侧手术治疗1例及文献复习[J]. 山东大学学报 (医学版), 2023, 61(2): 65-71.

MA Chenbang, GAO Pei, CHANG Yao, MAO Changlin, CHEN Feng, ZHU Kejia, GUAN Yong, LI Shanjun, DING Sentai. A case of non-tuberous sclerosis complex with giant angiomyolipoma of both kidneys treated with simultaneous resection and literature review[J]. Journal of Shandong University (Health Sciences), 2023, 61(2): 65-71.

参考文献

[1] Hatano T, Egawa S. Renal angiomyolipoma with tuberous sclerosis complex: how it differs from sporadic angiomyolipoma in both management and care[J]. Asian J Surg, 2020, 43(10): 967-972.
[2] Arslan B, Gürkan O, Çetin B, et al. Evaluation of ABO blood groups and blood-based biomarkers as a predictor of growth kinetics of renal angiomyolipoma[J]. Int Urol Nephrol, 2018, 50(12): 2131-2137.
[3] Caliò A, Brunelli M, Segala D, et al. Angiomyolipoma of the kidney: from simple hamartoma to complex tumour[J]. Pathology, 2021, 53(1): 129-140.
[4] Fernández-Pello S, Hora M, Kuusk T, et al. Management of sporadic renal angiomyolipomas: a systematic review of available evidence to guide recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel[J]. Eur Urol Oncol, 2020, 3(1): 57-72.
[5] Anis O, Rimon U, Ramon J, et al. Selective arterial embolization forlarge or symptomatic renal angiomyolipoma: 10 years of follow-up[J]. Urology, 2020, 135: 82-87. doi: 10.1016/j.urology.2019.09.035.
[6] Park BK. Renal angiomyolipoma based on new classification: how to differentiate it from renal cell carcinoma[J]. AJR Am J Roentgenol, 2019, 212(3): 582-588.
[7] Sahni VA, Silverman SG. Imaging management of incidentally detected small renal masses[J]. Semin Intervent Radiol, 2014, 31(1): 9-19.
[8] Yu J, Astrinidis A, Howard S, et al. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways[J]. Am J Physiol Lung Cell Mol Physiol, 2004, 286(4): L694-L700.
[9] Volpi A, Sala G, Lesma E, et al. Tuberous sclerosis complex: new insights into clinical and therapeutic approach[J]. J Nephrol, 2019, 32(3): 355-363.
[10] Bissler JJ, Kingswood JC. Renal angiomyolipomata[J]. Kidney Int, 2004, 66(3): 924-934.
[11] Halpenny D, Snow A, Mcneill G, et al. The radiological diagnosis and treatment of renal angiomyolipoma-current status[J]. Clin Radiol, 2010, 65(2): 99-108.
[12] Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1[J]. Science, 1994, 266(5182): 66-71.
[13] Dason ES, Drost L, Greenblatt EM, et al. Providers perspectives on the reproductive decision-making of BRCA-positive women[J]. BMC Womens Health, 2022, 22(1): 506. doi: 10.1186/s12905-022-02093-2.
[14] Manke IA, Lowery DM, Nguyen A, et al. BRCT repeats as phosphopeptide-binding modules involved in protein targeting[J]. Science, 2003, 302(5645): 636-639.
[15] Fazekas T, Széles áD, Teutsch B, et al. Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients- a systematic review and meta-analysis[J]. Prostate Cancer Prostatic Dis, 2022. doi: 10.1038/s41391-022-00626-2.
[16] Shah I, Silva-Santisteban A, Germansky KA, et al. Association between family history and risk of pancreatic cancer in patients with BRCA1 and BRCA2 pathogenic variants[J]. Pancreas, 2022, 51(7): 733-738.
[17] Drost R, Bouwman P, Rottenberg S, et al. BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance[J]. Cancer Cell, 2011, 20(6): 797-809.
[18] Friedman LS, Ostermeyer EA, Szabo CI, et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families[J]. Nat Genet, 1994, 8(4): 399-404.
[19] Choi E, Mun GI, Lee J, et al. BRCA1 deficiency in triple-negative breast cancer: protein stability as a basis for therapy[J]. Biomed Pharmacother, 2022, 158: 114090. doi: 10.1016/j.biopha.2022.114090.
[20] Filipponi D, Muller J, Emelyanov A, et al. Wip1 controls global heterochromatin silencing via ATM/BRCA1-dependent DNA methylation[J]. Cancer Cell, 2016, 30(2): 361-362.
[21] Kapur P, Rajaram S, Brugarolas J. The expanding role of BAP1 in clear cell renal cell carcinoma[J]. Hum Pathol, 2022: S0046-8177(22)00206-4. doi: 10.1016/j.humpath.2022.07.022.
[22] Dang CV. MYC on the path to cancer[J]. Cell, 2012, 149(1): 22-35.
[23] Donati G, Amati B. MYC and therapy resistance in cancer: risks and opportunities[J]. Mol Oncol, 2022, 16(21): 3828-3854.
[24] Anatskaya OV, Vinogradov AE. Polyploidy and Myc proto-oncogenes promote stress adaptation via epigenetic plasticity and gene regulatory network rewiring[J]. Int J Mol Sci, 2022, 23(17): 9691.
[25] Vamvakas S, Bittner D, Köster U. Enhanced expression of the protooncogenes c-myc and c-fos in normal and malignant renal growth[J]. Toxicol Lett, 1993, 67(1-3): 161-172.
[26] Hollander MC, Blumenthal GM, Dennis PA. PTEN loss in the continuum of common cancers, rare syndromes and mouse models[J]. Nat Rev Cancer, 2011, 11(4): 289-301.
[27] Glybochko PV, Alyaev YG, Khokhlachev SB, et al. 3D reconstruction of CT scans aid in preoperative planning for sarcomatoid renal cancer: a case report and mini-review[J]. J Xray Sci Technol, 2019, 27(2): 389-395.
[28] Elhadidi M, Aldahouk A, Shawky M, et al. Computer-guided calvarial mono-cortical bone blocks harvest: a novel approach for three-dimensional alveolar reconstruction of atrophic maxilla[J]. Clin Implant Dent Relat Res, 2019, 21(1): 85-93.

相关文章 15

[1]	曾彦平,闫圣涛,刘小瑜,江子晴. 以甲状旁腺危象为首发表现的甲状旁腺癌1例文献报道[J]. 山东大学学报 (医学版), 2023, 61(1): 62-68.
[2]	王陆敏,周士英,黄启坤,刘艳丽. DNAH5基因新发突变致原发性纤毛运动障碍1例[J]. 山东大学学报 (医学版), 2022, 60(8): 103-108.
[3]	靳鲁珺,林雪艳,刘天航,李青,李晓文,房蕾,孙浩,田永杰. 重度盆腔器官脱垂患者治疗选择及影响因素[J]. 山东大学学报 (医学版), 2022, 60(12): 39-43.
[4]	陈峰,高沛,朱可嘉,丁森泰. 膀胱淋巴上皮瘤样癌1例[J]. 山东大学学报 (医学版), 2022, 60(1): 118-120.
[5]	王沂峰,何丽清. 外阴癌腹股沟淋巴结手术的研究进展[J]. 山东大学学报 (医学版), 2021, 59(9): 103-109.
[6]	霍素霞,刘薇,王鑫. 86例Ⅲ型瘢痕妊娠诊治体会[J]. 山东大学学报 (医学版), 2021, 59(1): 40-44.
[7]	高沛,毛昌琳,陈峰,何维,管勇,吕家驹,李善军,丁森泰. CT三维重建改良R.E.N.A.L.评分系统在50例腹腔镜肾部分切除术中的应用[J]. 山东大学学报 (医学版), 2020, 1(9): 52-57.
[8]	孙志刚,时鹏,田兴松. 乳腺癌术后促纤维增生性肌纤维母细胞瘤1例[J]. 山东大学学报 (医学版), 2020, 58(1): 121-124.
[9]	高洪杰,刘华卫. 1例Omenn综合征患儿的临床特点及基因突变[J]. 山东大学学报 (医学版), 2019, 57(3): 120-124.
[10]	姚旭东. 局部晚期前列腺癌手术治疗策略及疗效[J]. 山东大学学报 (医学版), 2019, 57(1): 21-25.
[11]	关明,张心菊. 数字PCR在肿瘤诊疗中的应用进展[J]. 山东大学学报 (医学版), 2018, 56(10): 46-50.
[12]	余之刚,王斐. 乳腺癌多基因检测的再思考:机遇与挑战[J]. 山东大学学报 (医学版), 2018, 56(1): 22-26.
[13]	刘荫华,赵婧祎,辛灵. 美国临床肿瘤学会多基因检测临床实践指南更新及临床意义[J]. 山东大学学报 (医学版), 2018, 56(1): 1-5.
[14]	蒋洁,张晓黎,董明,刘金波,蒋玲. 肿瘤相关性骨软化症3例分析并文献复习[J]. 山东大学学报（医学版）, 2017, 55(5): 108-111.
[15]	梁璐,梁凯,蒋玲,张晓黎. 两例家族性Gitelman综合征患者基因型和表型特点[J]. 山东大学学报（医学版）, 2016, 54(12): 86-89.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed